Page last updated: 2024-08-23

idarubicin and Hyperplasia

idarubicin has been researched along with Hyperplasia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ananiev, GE; Goel, SA; Guo, LW; Guo, S; Hoffmann, FM; Kent, KC; Roenneburg, D; Wang, B	1

Other Studies

1 other study(ies) available for idarubicin and Hyperplasia

Article	Year
High-throughput screening identifies idarubicin as a preferential inhibitor of smooth muscle versus endothelial cell proliferation. PloS one, 2014, Volume: 9, Issue:2 Topics: Animals; Cell Proliferation; Cells, Cultured; Endothelial Cells; High-Throughput Screening Assays; Humans; Hyperplasia; Idarubicin; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rats, Sprague-Dawley; Tunica Intima	2014

Article

Year

High-throughput screening identifies idarubicin as a preferential inhibitor of smooth muscle versus endothelial cell proliferation.

PloS one, 2014, Volume: 9, Issue:2

Topics: Animals; Cell Proliferation; Cells, Cultured; Endothelial Cells; High-Throughput Screening Assays; Humans; Hyperplasia; Idarubicin; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rats, Sprague-Dawley; Tunica Intima

2014